Carl Gerdine Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 746a Putnam Blvd, Wallingford, PA 19086 Phone: 610-312-1626 |
Andrew Gibson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 104 Carleton Rd, Wallingford, PA 19086 Phone: 610-565-1970 |
Lisa Marie Costantini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 403 Saybrook Ln, Wallingford, PA 19086 Phone: 856-381-2913 |
Dr. John Anthony Williamson, PHARMD Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 415 Golfview Rd, Wallingford, PA 19086 Phone: 610-892-2928 Fax: 610-892-7920 |
News Archive
Green parenting - more than just a trendy movement - is the best way to raise healthy babies with lasting results. Parents today feel overwhelmed by all the choices and conflicting information when starting a family.
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has completed a detailed scientific review of the evidence surrounding reports of two syndromes, complex regional pain syndrome (CRPS) and postural orthostatic tachycardia syndrome (POTS) in young women given human papillomavirus (HPV) vaccines.
The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.
The number of people with diabetes worldwide will continue to increase at record levels through 2030, with the greatest relative increase in prevalence expected in the Middle Eastern Crescent, sub-Saharan Africa and India, according to a study published in the May issue of Diabetes Care.
ProTip SAS, the specialist developer of innovative medical devices for patients suffering from laryngeal malfunction, and Strasbourg University Hospitals today announce that they have successfully completed the first implantation of an artificial larynx in a human patient.
› Verified 8 days ago